• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过荟萃分析对获得性紫杉烷耐药靶向基因进行基因优先级排序和网络拓扑分析

Gene Prioritization and Network Topology Analysis of Targeted Genes for Acquired Taxane Resistance by Meta-Analysis.

作者信息

Kim Dongha, Lee Young Seok, Kim Jin Ki, Kim Sung Young

机构信息

Department of Biochemistry, School of Medicine, Konkuk University, Seoul, Korea.

出版信息

Crit Rev Eukaryot Gene Expr. 2019;29(6):581-597. doi: 10.1615/CritRevEukaryotGeneExpr.2019026317.

DOI:10.1615/CritRevEukaryotGeneExpr.2019026317
PMID:32422012
Abstract

Network topology-based approaches prove to be highly efficient in addressing multifactorial phenomena such as acquired drug resistance in cancer. The aim of this study was to identify differentially expressed genes across multiple microarray datasets (meta-DEGs), to prioritize meta-DEGs to find the most promising genes linked to acquired taxane resistance (ATR), and to analyze the relevant biological networks using topology analysis. A total of 771 meta-DEGs were identified by performing a cross-platform meta-analysis of ATR-related microarray datasets. A gene prioritization method was used to simultaneously identify activated or deactivated genes on a co-expression map and protein-protein interaction (PPI) network. The top 10 prioritized genes in the gene co-expression and the top 1% highly ranked genes in the PPI network were identified. The selected meta-DEGs were used to construct biological networks, and topological analysis was performed using network centrality measures. Using integrative analyses, we identified ATR candidate genes, including several previously unidentified genes that were found to be associated with ATR. From the gene co-expression network, PRSS23 was the highest-ranking gene at local average connectivity measure and ADAM9 was ranked highest in other centralities. In protein interaction network, HSPA1A, ANXA1, and PA2G4 showed highest ranks in network centrality analyses. This study provides a comprehensive overview of the gene expression patterns associated with ATR. Furthermore, it presents a new approach to identification of unveiled candidate genes to ATR, using a gene prioritization method and network analysis.

摘要

基于网络拓扑的方法在解决多因素现象(如癌症中的获得性耐药)方面被证明是非常有效的。本研究的目的是在多个微阵列数据集(元差异表达基因)中识别差异表达基因,对元差异表达基因进行优先级排序以找到与获得性紫杉烷耐药(ATR)相关的最有前景的基因,并使用拓扑分析来分析相关的生物网络。通过对与ATR相关的微阵列数据集进行跨平台元分析,共鉴定出771个元差异表达基因。使用一种基因优先级排序方法,在共表达图谱和蛋白质-蛋白质相互作用(PPI)网络上同时识别激活或失活的基因。确定了基因共表达中排名前10的基因以及PPI网络中排名前1%的高排名基因。所选的元差异表达基因用于构建生物网络,并使用网络中心性度量进行拓扑分析。通过综合分析,我们鉴定出了ATR候选基因,包括几个以前未被识别但被发现与ATR相关的基因。在基因共表达网络中,PRSS23在局部平均连通性度量中是排名最高的基因,而ADAM9在其他中心性中排名最高。在蛋白质相互作用网络中,HSPA1A、ANXA1和PA2G4在网络中心性分析中显示出最高排名。本研究全面概述了与ATR相关的基因表达模式。此外,它还提出了一种新的方法,即使用基因优先级排序方法和网络分析来识别尚未揭示的ATR候选基因。

相似文献

1
Gene Prioritization and Network Topology Analysis of Targeted Genes for Acquired Taxane Resistance by Meta-Analysis.通过荟萃分析对获得性紫杉烷耐药靶向基因进行基因优先级排序和网络拓扑分析
Crit Rev Eukaryot Gene Expr. 2019;29(6):581-597. doi: 10.1615/CritRevEukaryotGeneExpr.2019026317.
2
Topological network analysis of differentially expressed genes in cancer cells with acquired gefitinib resistance.对获得性吉非替尼耐药癌细胞中差异表达基因的拓扑网络分析
Cancer Genomics Proteomics. 2015 May-Jun;12(3):153-66.
3
Integrative meta-analysis of multiple gene expression profiles in acquired gemcitabine-resistant cancer cell lines to identify novel therapeutic biomarkers.对获得性吉西他滨耐药癌细胞系中多个基因表达谱进行综合荟萃分析,以鉴定新的治疗生物标志物。
Asian Pac J Cancer Prev. 2015;16(7):2793-800. doi: 10.7314/apjcp.2015.16.7.2793.
4
Identification of novel therapeutic target genes in acquired lapatinib-resistant breast cancer by integrative meta-analysis.通过整合荟萃分析鉴定获得性拉帕替尼耐药乳腺癌中的新型治疗靶点基因
Tumour Biol. 2016 Feb;37(2):2285-97. doi: 10.1007/s13277-015-4033-7. Epub 2015 Sep 11.
5
Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.构建帕金森病标志物加权蛋白质-蛋白质相互作用网络,对共表达基因进行优先级排序。
Gene. 2019 May 20;697:67-77. doi: 10.1016/j.gene.2019.02.026. Epub 2019 Feb 16.
6
Cross-platform meta-analysis of multiple gene expression profiles identifies novel expression signatures in acquired anthracycline-resistant breast cancer.多基因表达谱的跨平台荟萃分析确定了获得性蒽环类耐药乳腺癌中的新型表达特征。
Oncol Rep. 2015 Apr;33(4):1985-93. doi: 10.3892/or.2015.3810. Epub 2015 Feb 17.
7
Identification of Transcriptional Markers and microRNA-mRNA Regulatory Networks in Colon Cancer by Integrative Analysis of mRNA and microRNA Expression Profiles in Colon Tumor Stroma.基于结直肠肿瘤基质中 mRNA 和 microRNA 表达谱的综合分析鉴定结直肠癌中的转录标志物和 microRNA-mRNA 调控网络。
Cells. 2019 Sep 8;8(9):1054. doi: 10.3390/cells8091054.
8
Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.通过对微阵列数据的生物信息学分析揭示胶质瘤和神经胶质瘤发病机制的分子机制。
Med Oncol. 2017 Sep 26;34(11):182. doi: 10.1007/s12032-017-1043-x.
9
Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.通过生物信息学分析和体外实验鉴定结直肠癌肝转移的关键基因和 microRNAs。
Oncol Rep. 2019 Jan;41(1):279-291. doi: 10.3892/or.2018.6840. Epub 2018 Nov 1.
10
Gene expression profiling of epithelial ovarian cancer reveals key genes and pathways associated with chemotherapy resistance.上皮性卵巢癌的基因表达谱分析揭示了与化疗耐药相关的关键基因和通路。
Genet Mol Res. 2016 Jan 22;15(1):gmr7496. doi: 10.4238/gmr.15017496.

引用本文的文献

1
Transforming growth factor-β (TGF-β) signaling pathway-related genes in predicting the prognosis of colon cancer and guiding immunotherapy.转化生长因子-β(TGF-β)信号通路相关基因在预测结肠癌预后及指导免疫治疗中的作用
Cancer Pathog Ther. 2023 Dec 12;2(4):299-313. doi: 10.1016/j.cpt.2023.12.002. eCollection 2024 Oct.
2
Multi-time scale transcriptomic analysis on the dynamic process of tamoxifen resistance development in breast cancer cell lines.多时间尺度转录组分析乳腺癌细胞系中他莫昔芬耐药发展的动态过程。
Breast Cancer. 2022 May;29(3):458-467. doi: 10.1007/s12282-021-01325-x. Epub 2022 Jan 18.